Mirae Asset Global Etfs Holdings Ltd. Enanta Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 9,762 shares of ENTA stock, worth $111,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,762Holding current value
$111,189% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
99Shares Held
21.2MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$23.9 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$21 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$16.6 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$14.3 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $236M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...